R&G PharmaStudies Co., Ltd. announced on 25 April 2023 the profit distribution proposal for 2022 as follows: Cash dividend/10 shares (tax included): CNY 2.50000000.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
44.49 CNY | +1.58% | +1.02% | -31.00% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-31.00% | 590M | |
+25.52% | 88.99B | |
-24.52% | 74.82B | |
+0.49% | 25.03B | |
+4.31% | 17.88B | |
-14.25% | 16.43B | |
+2.97% | 15.77B | |
+79.20% | 13.21B | |
+70.11% | 13.08B | |
+40.44% | 12.9B |
- Stock Market
- Equities
- 301333 Stock
- News R&G PharmaStudies Co., Ltd.
- R&G Pharmastudies Co., Ltd. Proposes Cash Final Dividend for 2022